Key facts
- It has raised $3.0M; the latest was Early Stage VC ($3.0M) in Oct 2025.
- Notable investors include iM Investment Partners, DPH Capital, NH Capital, Behigh Investment, Kiwoom Securities — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Dr.ROOTEM
- ·The full record, as it builds
Funding rounds
No funding rounds for Dr.ROOTEM are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dr.ROOTEM
Operator of an online medicine firm intended for general health. The company provides medicine for memory, cognition, immunity, gut, joints, and bones among others, enabling customers to get medicines recommended by a doctor.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2022
- Website
- drrootem.com/
- Ownership
- Privately Held (backing)
Dr.ROOTEM doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dr.ROOTEM shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dr.ROOTEM in its N-PORT filings yet. We sweep new filings monthly.